<--- Back to Details
First PageDocument Content
Macular degeneration / Choroidal neovascularization / Ranibizumab / Vascular endothelial growth factor / Bevacizumab / Retinal pigment epithelium / Maculopathy / Retina / Drusen / Medicine / Ophthalmology / Health
Date: 2014-08-06 20:06:19
Macular degeneration
Choroidal neovascularization
Ranibizumab
Vascular endothelial growth factor
Bevacizumab
Retinal pigment epithelium
Maculopathy
Retina
Drusen
Medicine
Ophthalmology
Health

MD Research News Issue 192 Tuesday 5 August, 2014 This free weekly bulletin lists the latest published research articles on macular degeneration (MD) and some

Add to Reading List

Source URL: www.mdfoundation.com.au

Download Document from Source Website

File Size: 229,71 KB

Share Document on Facebook

Similar Documents

An Automated Drusen Detection System for Classifying Age-Related Macular Degeneration with Color Fundus Photographs

An Automated Drusen Detection System for Classifying Age-Related Macular Degeneration with Color Fundus Photographs

DocID: 1qyDV - View Document

MACULART meeting PARISFIRST ANNOUNCEMENTJUNE 2015

MACULART meeting PARISFIRST ANNOUNCEMENTJUNE 2015

DocID: 1auUM - View Document

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

DocID: 19zgB - View Document

MACULAR DEGENERATION Age related Macular Degeneration (ARMD) Age-related macular degeneration (ARMD) is the most common cause of irreversible vision loss in people over age of 60 years. Retina is the seeing tissue of the

MACULAR DEGENERATION Age related Macular Degeneration (ARMD) Age-related macular degeneration (ARMD) is the most common cause of irreversible vision loss in people over age of 60 years. Retina is the seeing tissue of the

DocID: 17SBz - View Document

Age-related Macular 	 Degeneration

Age-related Macular Degeneration

DocID: 14D7H - View Document